Navigation Links
Did Eli Lilly Turn Wily With Regard to Their Best-selling Schizophrenia Drug?

Eli Lilly, the pharmaceutical company, is in a tight spot, defending its position against the law suits from mentally ill patients//, about the company’s best-selling schizophrenia drug, Zyprexa. The company is being blamed for undermining the health risks of the drug, which is being linked to obesity and high blood sugar.

On the basis of many supporting documents and internal communication between managers in the company, ample evidence has surfaced, that the company has indeed kept under wraps, the harmful side-effects of the drug Zyprexa.

Even the company’s published statistics which the sales representatives have been tutored to make light of, portrays statistics that about 30% of the patients consuming Zyprexa, have gained 22 pounds within a year of consuming the drug and some have gained as much as 100 pounds. The documents clearly portray the abiding worry of the company that its sales might plummet if they were honest about the drug’s effect on weight gain or blood sugar levels.

The company has not taken the allegation lightly and has completely denied it. Lilly explained that the FDA has been enabled with a clear picture of all the clinical trials and reviews regarding the usage of the drug world-wide. But documents in circulation within the company relates to an entirely different story. Apprehension regarding the drug’s side effects has been debated as early as 1999, to the extent that company bigwigs felt it could jeopardize the sales of their most popular product, if it were publicized.


AV
'"/>




Page: 1

Related medicine news :

1. Animal insulin product to be discontinued by drug major Eli Lilly
2. Eli Lilly Releases Digital Insulin Pen
3. Researchers Present Data Regarding The Efficiency Of Herbs
4. Changing Trends Regarding Insurance Cover For Weight Reduction Surgery
5. Leeches Provide Clues Regarding The Prevention Of Heart Disease
6. Legal Action against Authority Regarding Outbreak of Legionnaires’ Diseas
7. Mixed Opinion Regarding Common Medical And Engineering Entrance Test
8. Adolescents Influenced By Maternal Attitude Regarding Weight Control
9. Reforms Required With Regard To Mental Health Facilities
10. Tension between MP And the Cancer Council Head Regarding Screening Test for Male Cancer
11. A Just Published Book Promises To Guide Women Regarding Their Frequent UTI’
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2017)... ... 23, 2017 , ... PureLife Dental is pleased to announce that California Dental ... As part of the amalgam separator endorsement, all CDA members may purchase an ECO ... the retail value. This partnership between PureLife and CDA is especially timely as it ...
(Date:6/23/2017)... , ... June 23, 2017 , ... ... financial planning, and related services to families and business owners in and around ... drive to benefit senior citizens in the area. , Meals on Wheels of ...
(Date:6/23/2017)... ... June 23, 2017 , ... Moore Insurance, ... area with access to asset protection and financial planning services, is teaming up ... improving the lives of children with cancer and other chronic diseases. , The ...
(Date:6/22/2017)... ... June 22, 2017 , ... Groove Ring is excited to ... their high performance silicon wedding bands and all-purpose rings. Whether you’re an athlete, adventurer, ... rings designed just for you. , From the rock face to the auto shop, ...
(Date:6/22/2017)... ... June 22, 2017 , ... ... today that it has received certification for ANSI/ASIS PSC.1-2012. The company’s work in ... environments where the rule of law has been degraded. The PSC.1 standard was ...
Breaking Medicine News(10 mins):
(Date:6/20/2017)... -- Hill-Rom Holdings, Inc. (NYSE: HRC), will host its fiscal third ... 28, 2017, beginning at 7:30 a.m. (CDT) / 8:30 a.m. ... participate in the conference call, dial (877) 304-8969 (domestic) or ... 10 minutes prior to the start to allow time to ... Webcast: A simultaneous webcast of the call ...
(Date:6/14/2017)... -- ivWatch LLC, a medical device company focused on improving ... pleased to announce it was the Bronze Winner last ... Equipment at the 2017 Medical Design Excellence Awards (MDEAs), ... award was presented by Medical Device and Diagnostics Industry ... New York during MD&M East, the ...
(Date:6/12/2017)... 2017 Kineta, Inc., a biotechnology company focused on ... Vice President of R&D and Head of Virology Kristin Bedard ... for the Northwest and Beyond meeting sponsored by Life ... 2017 from 8:30-10:30 AM PDT at the Agora Conference Center ... Dr. Bedard will be joined by other leaders in infectious ...
Breaking Medicine Technology: